Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03933930

Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy.

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Taipei Medical University WanFang Hospital · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Hyperthermic intraperitoneal chemotherapy is a major surgery for tumor peritoneal metastasis. For anesthesiologist, the intra-operative fluid control is always a big challenge. We try to compare the prognosis of lactate-directed and goal-directed therapy. We expect to confirm the better prognosis of lactate-directed therapy.

Conditions

Interventions

TypeNameDescription
OTHERLactate-directed therapyIf the lactate level elevates, we transfuse pRBC to increase Hct\>30%. If Hct \>30%, dopamine infusion starts.
OTHERGoal-directed therapyIf SVV\>15%, transfuse lactate ringer/normal saline alternatively to keep SVV\<15%.

Timeline

Start date
2019-05-06
Primary completion
2021-05-15
Completion
2021-05-15
First posted
2019-05-01
Last updated
2020-06-04

Source: ClinicalTrials.gov record NCT03933930. Inclusion in this directory is not an endorsement.